Cellular Immunity Status of Children With β-Thalassemia
نویسندگان
چکیده
منابع مشابه
Total Antioxidant Status in Patients with Major β-Thalassemia
OBJECTIVE Beta-thalassemia major is an autosomal recessive disease causing severe and hemolytic anemia, which begins about 2-6 months after birth. Iron overload, which arises from recurrent transfusion and ineffective erythropoiesis, can enhance oxidative stress in thalassemic patients. The aim of this study was to evaluate the serum total antioxidant capacity of patients with ß-Thalassemia maj...
متن کاملQuality of Life in Children with Β-Thalassemia Major at Center for Special Diseases
Abstract Background Knowledge of factors associated with quality of life in patients with thalassemia is necessary for creating appropriate clinical programs, social support, and improving treatment outcomes. The purpose of this study was to determine quality of life in children with thalassemia major at Center for Special Diseases of valiasr hospital in Birjand. Materials and Methods This...
متن کاملHypocholesterolemia in children and adolescents with β-thalassemia intermedia
Low plasma levels of total cholesterol (TC) with or without hypertriglyceridemia have been frequently described in a variety of hematologic disorders in which anemia is a prominent feature.2,3 It is well established that β-thalassemia is associated with changes in plasma lipids and lipoproteins. In β-thalassemia major, low cholesterol levels caused by a significant reduction of both low-density...
متن کاملEvaluation of the relationship between growth status and dietary intake in 10 children with thalassemia major
Introduction: Thalassemia major is the most common inheritable disease in Iran with high prevalence in Fars province. Growth retardation is prevalent in this patients, mainly due to malnutrition. The aim Goal of this study was to determine the relationship between growth status and nutritional intake. Patients under 10 years old with thalassemia major. Methods: In this cross-sectional stu...
متن کاملTherapeutic approaches in patients with β-thalassemia
Beta-thalassemia (β-thal) is a congenital hemoglobinopathy explained by a decreased level (β+) or absence (βο) of β-globin gene expression. Microcytic hypochromic anemia and various clinical symptoms comprising severe anemia to clinically nonsymptomatic features. Treatment with an ordered blood transfusion and iron chelator agents can decrease transfusion iron overload that causes normal matura...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Research
سال: 1999
ISSN: 0031-3998,1530-0447
DOI: 10.1203/00006450-199905010-00111